SV2A PET reveals synaptic density loss in experimental autoimmune encephalomyelitis and in a pilot multiple sclerosis study. [PDF]
Chia PHJ +13 more
europepmc +1 more source
The central neurometabolic fingerprint of persistent spinal pain syndrome type 2: A prospective [<sup>18</sup>F]FDG PET/CT neuroimaging study. [PDF]
Burmeister LS +11 more
europepmc +1 more source
Seletracetam Revisited: A Missed Opportunity for Effective Epilepsy Therapy. [PDF]
Löscher W +4 more
europepmc +1 more source
Lower synaptic density in mood circuitry underlies depression in Parkinson's disease. [PDF]
Cayir S +19 more
europepmc +1 more source
Decomposing SV2A Function and Dysfunction one Neuron at a Time. [PDF]
Safari M, Weston MC.
europepmc +1 more source
High-resolution in utero SV2A PET imaging of the nonhuman primate brain using the NeuroEXPLORER. [PDF]
Mehta S +15 more
europepmc +1 more source
Whole brain grey matter synaptic terminal density, age and intellectual functioning in schizophrenia: an in vivo [<sup>11</sup>C]UCB-J positron emission tomography study. [PDF]
Onwordi EC +16 more
europepmc +1 more source
Role of α-Synuclein in the Prefrontal Cortex: From Physiological Synaptic Modulation to Synaptic Failure in Parkinson's Disease. [PDF]
Argibay U +7 more
europepmc +1 more source
Levetiracetam prevents Aβ production through SV2a-dependent modulation of APP processing in Alzheimer's disease models. [PDF]
Rao NR +16 more
europepmc +1 more source

